Treace Medical Concepts Inc (TMCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,350 | 12,110 | 18,181 | 9,334 | 12,982 |
| Marketable Securities | 64,327 | 70,689 | 76,865 | 100,672 | 110,216 |
| Receivables | 40,803 | 24,177 | 25,559 | 30,083 | 38,063 |
| Inventories | 39,255 | 43,611 | 41,279 | 35,860 | 29,245 |
| TOTAL | $161,402 | $157,602 | $171,552 | $187,397 | $198,359 |
| Non-Current Assets | |||||
| PPE Net | 25,953 | 25,168 | 24,245 | 24,517 | 22,298 |
| Intangibles | 20,890 | 21,127 | 21,365 | 21,602 | 21,840 |
| Other Non-Current Assets | 8,849 | 9,027 | 8,921 | 9,210 | 9,410 |
| TOTAL | $55,692 | $55,322 | $54,531 | $55,329 | $53,548 |
| Total Assets | $217,094 | $212,924 | $226,083 | $242,726 | $251,907 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,522 | 18,649 | 18,073 | 21,149 | 11,835 |
| Accrued Expenses | 23,893 | 19,043 | 25,853 | 24,878 | 28,766 |
| Other current liabilities | 510 | 571 | 520 | 1,022 | 4,432 |
| TOTAL | $34,925 | $38,263 | $44,446 | $47,049 | $45,033 |
| Non-Current Liabilities | |||||
| Long Term Debt | 53,306 | 53,231 | 53,157 | 53,083 | 53,008 |
| Other Non-Current Liabilities | 15,971 | 16,524 | 16,339 | 16,203 | 15,928 |
| TOTAL | $69,277 | $69,755 | $69,496 | $69,286 | $68,936 |
| Total Liabilities | $104,202 | $108,018 | $113,942 | $116,335 | $113,969 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,619 | 62,297 | 62,190 | 62,008 | 61,755 |
| Common Shares | 62 | 62 | 62 | 62 | 62 |
| Retained earnings | -189,990 | -189,489 | -174,129 | -152,923 | -134,247 |
| Other shareholders' equity | -184 | -59 | -276 | -181 | 150 |
| TOTAL | $112,892 | $104,906 | $112,141 | $126,391 | $137,938 |
| Total Liabilities And Equity | $217,094 | $212,924 | $226,083 | $242,726 | $251,907 |